The US Leader in Stem Cell Therapy, Now in Mexico. Treatments start at $3750 for 25 million stem cells!
Special Promo: Get an additional 25 BILLION Exosomes IV with treatments over 50 million cells!”
The US Leader in Stem Cell Therapy, Now in Mexico. Affordable treatments start at $3750 for 25 million stem cells!
Special Promo: Get an additional 25 BILLION Exosomes IV with treatments over 50 million cells!”
Written by Dr. David Greene, MD, PhD, MBA on July 2, 2025
Multiple Sclerosis is an immune disorder in which the immune system starts targeting the myelin sheath of the neurons present in the brain and the spinal cord. Damage sustained by the myelin sheath of the neurons results in the failure of the communications to take place among the neurons.
The patients of this disease are likely to develop all kinds of physical, psychiatric and mental problems as their disease advances. Currently there is no cure present for treating Multiple Sclerosis. Treatment strategies that are advised only stop the immune system from causing more damage to the myelin sheath and do not help in healing the damage suffered by them.
Advances in medical science has proven that the use of stem cells can prove to be an effective means of treatment for patients of Multiple Sclerosis as they are capable of replacing the damaged myelin sheath of the neurons, thereby, improving the capability of the neurons to communicate with each other.
The Mesenchymal Stem Cells have shown the most promise in this regard. These cells are supposed to have immune regulatory properties which enable them to prevent the immune system from damaging the myelin sheath. Moreover, these cells can also help the body in regeneration of this covering sheath of the neurons as well.
At the present moment, the Mesenchymal Stem Cells are being harvested from umbilical cord tissues donated for research after a healthy birth. There are many advantages of using the umbilical cord tissues for this purpose, the most important of which is that the Mesenchymal Stem Cells harvested from umbilical cords are not rejected by the body in which they are transplanted.
The immune system of the patient is not going to consider these stem cells as antigens since they are derived from human umbilical cords.
It is also possible to harvest stem cells from bone marrow or fat to be used for the MS treatment. In short, the use of stem cell therapy for MS is highly possible and starting to catch on due to early beneficial results. More research is currently being performed.
Physician First Choice offers stem cell therapy for many conditions such as MS, autism, COPD, Diabetes and much more. The stem cell clinic serves patients from a broad area, and the doctors are Board Certified.
Call 888-988-0515 for more information and scheduling today!
Contact US
About R3 Stem Cell Mexico
Follow Us
Quick Links
Disclaimer
Stem cell therapy is considered experimental and is regulated by the U.S. Food and Drug Administration (FDA), but it is not FDA-approved. R3 Stem Cell does not offer stem cell therapy as a cure for any medical condition. No statements made on this site have been evaluated or approved by the FDA. This site does not provide medical advice. All content is for informational purposes only and is not a substitute for professional medical consultation, diagnosis, or treatment. Reliance on any information provided by R3 Stem Cell, its employees, others appearing on this website at the invitation of R3 Stem Cell, or other visitors to the website is solely at your own risk. R3 Stem Cell does not recommend or endorse any specific tests, products, procedures, opinions, or other information that may be mentioned on this website. R3 Stem Cell is not responsible for the outcome of your procedure. The FDA considers stem cell therapy experimental at this point.
Contact Us
Copyright © 2016 – 2025 R3 Stem Cell
Dr. David Greene
MD, PhD, MBA
Dr. David Greene, MD, PhD, MBA, is a pioneering leader in regenerative medicine and healthcare marketing. As a residency and fellowship-trained orthopedic surgeon, Dr. Greene transitioned from clinical practice to become the founder and CEO of R3 Stem Cell and US Lead Network, where he has revolutionized patient care and medical practice growth through innovative therapies and digital marketing strategies. He has authored two influential books on healthcare internet marketing, ranks among the top expert authors globally, and has been featured on the cover of Corporate Vision magazine for his impact on global regenerative therapies. Beyond his professional achievements, Dr. Greene is passionate about education, compassion, and continuous innovation.